Mammaglobin-a immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 22, Issue 6, 2014, Pages 442-448

  Cimino, Patrick J ^a   Perrin, Richard J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumor; Breast carcinoma; Central nervous system; Metastasis

Indexed keywords

MAMMAGLOBIN A; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CENTRAL NERVOUS SYSTEM TUMOR; CYTOARCHITECTURE; EVALUATION STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRACRANIAL METASTATIC BREAST CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENINGIOMA; PRIMARY TUMOR; PRIORITY JOURNAL; STAINING; BRAIN TUMOR; BREAST TUMOR; CLASSIFICATION; CLINICAL TRIAL; FEMALE; METABOLISM; METASTASIS; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MAMMAGLOBIN A; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84904206255     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318294ca46     Document Type: Article

References (32)

1. Preusser M, Capper D, Ilhan-Mutlu A, et al. Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol. 2012;123:205-222.
2. Carroll RS, Zhang J, Dashner K, et al. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery. 1995;37:496-503; discussion 503-494.
3. Gonzalez-Aguero G, Ondarza R, Gamboa-Dominguez A, et al. Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res Bull. 2001;56:43-48.
4. Martinez R, Marcos ML, Figueras A, et al. Estrogen and progesterone receptors in intracranial tumors. Clin Neuropharmacol. 1984;7:338-342.
5. Mineo JF, Bordron A, Baroncini M, et al. Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma. J Neurooncol. 2007;85:281-287.
6. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol. 1997;28: 938-943.
7. Brandis A, Mirzai S, Tatagiba M, et al. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery. 1993;33:212-217; discussion 217-218.
8. Schlegel J, Ullrich B, Stumm G, et al. Expression of the c-erbB-2- encoded oncoprotein and progesterone receptor in human meningiomas. Acta Neuropathol. 1993;86:473-479.
9. Eckhardt BL, Francis PA, Parker BS, et al. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov. 2012;11:479-497.
10. Johnson DR, Chang SM. Recent medical management of glioblastoma. Adv Exp Med Biol. 2012;746:26-40.
11. Watson MA, Fleming TP. Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res. 1994;54:4598-4602.
12. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-865.
13. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin versus GCDFP- 15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007;127:103-113.
14. Fleming TP, Watson MA. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann NY Acad Sci. 2000;923:78-89.
15. Han JH, Kang Y, Shin HC, et al. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med. 2003;127:1330-1334.
16. Marchetti A, Buttitta F, Bertacca G, et al. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol. 2001;195:186-190.
17. O'Brien N, Maguire TM, O'Donovan N, et al. Mammaglobin a: a promising marker for breast cancer. Clin Chem. 2002;48:1362-1364.
18. Sasaki E, Tsunoda N, Hatanaka Y, et al. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol. 2007;20:208-214.
19. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
20. Onuma K, Dabbs DJ, Bhargava R. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Int J Gynecol Pathol. 2008;27:418-425.
21. Zafrakas M, Petschke B, Donner A, et al. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their coexpression in gynecologic malignancies. BMC Cancer. 2006;6:88-100.
22. Wang Z, Spaulding B, Sienko A, et al. Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. Int J Clin Exp Pathol. 2009;2:384-389.
23. Hagemann IS, Pfeifer JD, Cao D. Mammaglobin expression in gynecologic adenocarcinomas. Hum Pathol. 2013;44:628-635.
24. Rollins-Raval M, Chivukula M, Tseng GC, et al. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature. Arch Pathol Lab Med. 2011;135:975-983.
25. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599-608.
26. Carletti AM, Roncella S, Canessa PA, et al. Expression of human mammaglobin gene in pleural effusions of patients with malignant mesothelioma. Thorax. 2006;61:271.
27. Koga T, Horio Y, Mitsudomi T, et al. Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data. J Mol Diagn. 2004;6:90-95.
28. Sjodin A, Guo D, Sorhaug S, et al. Dysregulated secretoglobin expression in human lung cancers. Lung Cancer. 2003;41: 49-56.
29. Takeda Y, Tsuta K, Shibuki Y, et al. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008;132:239-243.
30. Zehentner BK, Carter D. Mammaglobin: a candidate diagnostic marker for breast cancer. Clin Biochem. 2004;37:249-257.
31. Gaedcke J, Traub F, Milde S, et al. Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol. 2007;20:864-870.
32. Yonemori K, Tsuta K, Shimizu C, et al. Immunohistochemical profiles of brain metastases from breast cancer. J Neurooncol. 2008;90:223-228.